FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313639131> ?p ?o ?g. }

• W4313639131 endingPage "479" @default.
• W4313639131 startingPage "471" @default.
• W4313639131 abstract "Abstract Objectives To evaluate the influence of febuxostat on adverse events and mortality in gout. Methods We retrospectively enrolled patients with newly diagnosed gout and prescribed urate‐lowering therapy between 2006 and 2017 from the Taiwan National Health Insurance Database. These patients were divided into 2 groups: with and without comorbidities ( n = 294 847 and 194 539). An interrupted time series analysis with adjustments for demographics, comorbidities, and comedication by propensity score‐based stabilized weights was used to compare the trend of adverse events and mortality before vs after febuxostat was introduced in 2012. Results The proportion of febuxostat use gradually increased from 0% in 2012 to 30% in those with comorbidities and 10% in those without comorbidities in 2017. Allopurinol use decreased from 30% in 2012 to 10% in 2017. The slope of the 1‐year incidence rate of Stevens–Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) (per 10 000 patients) significantly reduced after 2012 in those with and without comorbidities (−0.375 per quarter, P = .015 and −.253 per quarter, P = .049). The slope of the 3‐year incidence rate of acute myocardial infarction (AMI) (per 1000 patients), percutaneous coronary intervention (PCI) (per 1000 patients), and all‐cause mortality (per 100 patients) significantly increased after 2012 in those with comorbidities (+0.207 per quarter, P = .013; +.389 per quarter, P = .002; +.103 per quarter, P = .001). Conclusions Febuxostat may reduce SJS and TEN in all gout patients but increase AMI, PCI, and all‐cause mortality in gout patients with comorbidities." @default.
• W4313639131 created "2023-01-07" @default.
• W4313639131 creator A5010244810 @default.
• W4313639131 creator A5035573488 @default.
• W4313639131 creator A5052425370 @default.
• W4313639131 creator A5062523096 @default.
• W4313639131 creator A5072714961 @default.
• W4313639131 date "2023-01-06" @default.
• W4313639131 modified "2023-10-17" @default.
• W4313639131 title "Effect of febuxostat on adverse events and mortality in gout in Taiwan: An interrupted time series analysis" @default.
• W4313639131 cites W1557117565 @default.
• W4313639131 cites W2048359032 @default.
• W4313639131 cites W2048470090 @default.
• W4313639131 cites W2056108924 @default.
• W4313639131 cites W2066160935 @default.
• W4313639131 cites W2083508836 @default.
• W4313639131 cites W2102840015 @default.
• W4313639131 cites W2105092345 @default.
• W4313639131 cites W2110850245 @default.
• W4313639131 cites W2119537052 @default.
• W4313639131 cites W2126049444 @default.
• W4313639131 cites W2148364248 @default.
• W4313639131 cites W2150224561 @default.
• W4313639131 cites W2156142163 @default.
• W4313639131 cites W2159121887 @default.
• W4313639131 cites W2167491049 @default.
• W4313639131 cites W2217064679 @default.
• W4313639131 cites W2335302945 @default.
• W4313639131 cites W2515585355 @default.
• W4313639131 cites W2603332025 @default.
• W4313639131 cites W2790476331 @default.
• W4313639131 cites W2793103574 @default.
• W4313639131 cites W2794517761 @default.
• W4313639131 cites W2897652153 @default.
• W4313639131 cites W2912204240 @default.
• W4313639131 cites W2912716476 @default.
• W4313639131 cites W2914070822 @default.
• W4313639131 cites W2943005888 @default.
• W4313639131 cites W2945147512 @default.
• W4313639131 cites W2953825781 @default.
• W4313639131 cites W2953859254 @default.
• W4313639131 cites W2998636556 @default.
• W4313639131 cites W3009537962 @default.
• W4313639131 cites W3025042862 @default.
• W4313639131 cites W3043129483 @default.
• W4313639131 cites W3047222540 @default.
• W4313639131 cites W3049233926 @default.
• W4313639131 cites W3104282256 @default.
• W4313639131 cites W3160480599 @default.
• W4313639131 cites W3171915249 @default.
• W4313639131 cites W3197776846 @default.
• W4313639131 cites W4229537562 @default.
• W4313639131 cites W4237556338 @default.
• W4313639131 doi "https://doi.org/10.1111/1756-185x.14558" @default.
• W4313639131 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36608705" @default.
• W4313639131 hasPublicationYear "2023" @default.
• W4313639131 type Work @default.
• W4313639131 citedByCount "1" @default.
• W4313639131 countsByYear W43136391312023 @default.
• W4313639131 crossrefType "journal-article" @default.
• W4313639131 hasAuthorship W4313639131A5010244810 @default.
• W4313639131 hasAuthorship W4313639131A5035573488 @default.
• W4313639131 hasAuthorship W4313639131A5052425370 @default.
• W4313639131 hasAuthorship W4313639131A5062523096 @default.
• W4313639131 hasAuthorship W4313639131A5072714961 @default.
• W4313639131 hasConcept C120665830 @default.
• W4313639131 hasConcept C121332964 @default.
• W4313639131 hasConcept C126322002 @default.
• W4313639131 hasConcept C141071460 @default.
• W4313639131 hasConcept C179755657 @default.
• W4313639131 hasConcept C197934379 @default.
• W4313639131 hasConcept C2779159551 @default.
• W4313639131 hasConcept C2779721657 @default.
• W4313639131 hasConcept C2779881121 @default.
• W4313639131 hasConcept C2780261098 @default.
• W4313639131 hasConcept C2780400711 @default.
• W4313639131 hasConcept C2780402116 @default.
• W4313639131 hasConcept C2780932893 @default.
• W4313639131 hasConcept C45393284 @default.
• W4313639131 hasConcept C500558357 @default.
• W4313639131 hasConcept C61511704 @default.
• W4313639131 hasConcept C71924100 @default.
• W4313639131 hasConceptScore W4313639131C120665830 @default.
• W4313639131 hasConceptScore W4313639131C121332964 @default.
• W4313639131 hasConceptScore W4313639131C126322002 @default.
• W4313639131 hasConceptScore W4313639131C141071460 @default.
• W4313639131 hasConceptScore W4313639131C179755657 @default.
• W4313639131 hasConceptScore W4313639131C197934379 @default.
• W4313639131 hasConceptScore W4313639131C2779159551 @default.
• W4313639131 hasConceptScore W4313639131C2779721657 @default.
• W4313639131 hasConceptScore W4313639131C2779881121 @default.
• W4313639131 hasConceptScore W4313639131C2780261098 @default.
• W4313639131 hasConceptScore W4313639131C2780400711 @default.
• W4313639131 hasConceptScore W4313639131C2780402116 @default.
• W4313639131 hasConceptScore W4313639131C2780932893 @default.
• W4313639131 hasConceptScore W4313639131C45393284 @default.
• W4313639131 hasConceptScore W4313639131C500558357 @default.
• W4313639131 hasConceptScore W4313639131C61511704 @default.

• next